Travere Therapeutics Inc

Travere Therapeutics Inc

TVTX · NASDAQ
TVTX · NASDAQ
49.41
USD0.010.02%

Latest News

    @Benzinga
    Benzinga

    Oversold health care stocks are starting to catch traders’ attention as momentum indicators flash potential reversal signals. When RSI drops near or below 30, it often suggests selling pressure may be overdone, creating short term rebound opportunities. Travere Therapeutics is https://t.co/xKtLjRJnZq

      @Reuters
      Reuters

      U.S. FDA approves Travere Therapeutics kidney disorder drug https://t.co/pQRy09nBZH https://t.co/1N0TF6AFvC

        @Reuters
        Reuters

        U.S. FDA approves Travere Therapeutics kidney disorder drug https://t.co/CEYVJdNloa https://t.co/YAhrJ3yD0L

          @eWhispers
          eWhispers

          Upcoming #eanrings releases with the highest #volatility https://t.co/lObOE0dgsr $AAN $SM $DBD $RBBN $ATEN $BCOV $COHU $IMGN $TBI $BTU $CHEF $SPNE $MD $MGI $QS $EB $TVTX $RES https://t.co/GK0fX6Csud

          Analysts Recommendations

          Bullish

          Buy

          Strong Buy

          Buy

          Hold

          Sell

          Strong Sell

          Day Range

          44.73USD
          49.68USD

          52 Week Range

          22.59USD
          68.73USD

          Market Cap

          4.75BUSD

          lock-imagelock-image

          Get Full Access with Profit PRO

          See which Billionaires own this investment

          About

          General Information

          Type

          Common Stock

          Exchange

          NASDAQ

          Currency Code

          USD

          Currency Name

          US Dollar

          Country Name

          USA

          Country ISO

          US

          ISIN

          US89422G1076

          CUSIP

          89422G107

          Sector

          Healthcare

          Industry

          Biotechnology

          Fiscal Year End

          December

          IPO date

          -

          Updated At

          -

          Highlights

          PE Ratio

          -

          PEG Ratio

          -

          Book Value

          0.26

          Dividend Share

          -

          Dividend Yield

          -

          Earnings Share

          -0.74

          Wall Street Target Price

          75.21

          EPS Estimate Current Year

          1.45

          EPS Estimate Next Year

          5.39

          EPS Estimate Current Quarter

          0.4174

          EPS Estimate Next Quarter

          0.9314

          Most Recent Quarter

          -

          Profitability

          Revenue TTM

          591,329,984

          Gross Profit TTM

          350,115,008

          EBITDA

          22,913,000

          Profit Margin

          -7.35%

          Return On Assets TTM

          -3.73%

          Return On Equity TTM

          -236.36%

          Revenue Per Share TTM

          6.482

          Qtly Revenue Growth YOY

          48.20%

          Diluted Eps TTM

          -0.74

          Qtly Earnings Growth YOY

          0.00%

          Valuation

          Trailing PE

          0.00

          Forward PE

          37

          Price Sales TTM

          7.8523

          Price Book MRQ

          193.6577

          Enterprise Value Revenue

          8

          Enterprise Value EBITDA

          844

          Peers analysis

          • argenx NV ADR
            ARGXargenx NV ADR

            903.08

            3.20%
          • Moderna Inc
            MRNAModerna Inc

            227.40

            2.97%
          • Regeneron Pharmaceuticals Inc
            REGNRegeneron Pharmaceuticals Inc

            965.00

            0.55%
          • UCB SA
            UCBJFUCB SA

            314.92

            0.35%
          • argenx SE
            ARGNFargenx SE

            900.30

            0.00%
          • CSL Limited
            CMXHFCSL Limited

            139.16

            0.00%
          • Vertex Pharmaceuticals Inc
            VRTXVertex Pharmaceuticals Inc

            528.21

            -4.77%
          • Be
            ONCBeiGene, Ltd.

            355.10

            -2.26%
          • CSL Ltd
            CSLLYCSL Ltd

            34.64

            -2.01%
          • UCB SA ADR
            UCBJYUCB SA ADR

            153.70

            -1.47%

          FAQs

          What is Travere Therapeutics stock price today?

          What is Travere Therapeutics stock ticker?

          Is TVTX stock price going up?

          What is the analyst recommendation for TVTX?

          What is TVTX market cap?

          Does TVTX release financial reports?

          When is TVTX next earnings date?

          What were TVTX Earnings for the last quarter?

          What was TVTX Revenue for the last quarter?

          What was TVTX Net Income for the last quarter?

          Does TVTX pay dividends?

          How many employees does TVTX have?

          What is TVTX EBITDA?

          How to buy TVTX stocks?

          Should I invest in TVTX stock?